In the realm of diabetes management, two innovative medications have emerged as frontrunners: tirzepatide and semaglutide. Both therapies act on specific receptors within the body to control blood sugar levels, offering promising outcomes for individuals with type 2 diabetes. Nevertheless, these medications exhibit marked differences in their mecha